Literature DB >> 20615122

Effect of apelin-apelin receptor system in postischaemic myocardial protection: a pharmacological postconditioning tool?

Raffaella Rastaldo1, Sandra Cappello, Anna Folino, Gianni Losano.   

Abstract

In the heart, a great part of ischaemia and reperfusion injuries occurs mainly during the first minutes of reperfusion. The opening of the mitochondrial permeability transition pores is the end point of the cascade to myocardial damage. Also, oxidative stress contributes to cell death. Postconditioning is a protective maneuver that can be selectively timed at the beginning of reperfusion. It is hypothesized that it acts via the reperfusion injury salvage kinase pathway, which includes nitric oxide-dependent and nitric oxide-independent cascades. Apelin is an endogenous peptide that can protect the heart from reperfusion injury if given at the beginning of reperfusion but not before ischaemia. It is hypothesized that it may trigger the reperfusion injury salvage kinase pathway via a specific apelin receptor. Apelin can also limit the oxidative stress by the activation of superoxide dismutase. Apelin and apelin receptor expression increase early after ischaemia and at the beginning of an ischaemic heart failure. These observations suggest that the endogenous release of the peptide can limit the severity of an infarction and ameliorate myocardial contractility compromised by the appearance of the failure. Due to its protective activities, apelin could be a therapeutic tool if administered with the same catheter used for angioplasty or after the maneuvers aimed at bypassing a coronary occlusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615122     DOI: 10.1089/ars.2010.3355

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  Limitation of myocardial infarction by a structural analog of the peptide apelin-12.

Authors:  O I Pisarenko; Yu A Pelogeykina; Zh D Bespalova; L I Serebryakova; M V Sidorova; A A Az'muko; D N Khatri; I M Studneva; M E Pal'keeva; O V Tskitishvili; A S Molokoedov
Journal:  Dokl Biol Sci       Date:  2012-05-05

Review 2.  Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin.

Authors:  Carina Ureche; Laura Tapoi; Simona Volovat; Luminita Voroneanu; Mehmet Kanbay; Adrian Covic
Journal:  J Hum Hypertens       Date:  2019-01-18       Impact factor: 3.012

Review 3.  Effects of apelin on the cardiovascular system.

Authors:  Anna Folino; Pier Giorgio Montarolo; Michele Samaja; Raffaella Rastaldo
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Effect of leptin and apelin preconditioning on hepatic ischemia reperfusion injury in rats.

Authors:  Tamer Sagiroglu; Mustafa Burak Aksoy; Gonul Sagiroglu; Hilmi Tozkir; Serhat Oguz; Tulin Yalta; Mehmet A Yagci; Atakan Sezer
Journal:  Indian J Surg       Date:  2012-07-04       Impact factor: 0.656

Review 5.  Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential.

Authors:  Yili Wu; Xin Wang; Xuan Zhou; Baohua Cheng; Gongying Li; Bo Bai
Journal:  Front Mol Neurosci       Date:  2017-01-23       Impact factor: 5.639

6.  Correlation Between Apelin and Collateral Circulation in Patients with Middle Cerebral Artery Occlusion and Moyamoya Disease.

Authors:  Hanlin Wu; Chengyu Xia; Rui Li; Chunrong Tao; Qiqiang Tang; Wei Hu
Journal:  Int J Gen Med       Date:  2022-01-19

7.  Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure.

Authors:  Hui Pang; Bing Han; Tao Yu; Zhenkun Zong
Journal:  Int J Mol Med       Date:  2014-07-02       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.